Stay updated on CMP-001 with Pembrolizumab: Clinical Trial

Sign up to get notified when there's something new on the CMP-001 with Pembrolizumab: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CMP-001 with Pembrolizumab: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:08:57.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice about NIH terminology and website updates appears above the ClinicalTrials.gov study record.
    Difference
    0.6%
    Check dated 2026-10-24T14:28:19.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T14:21:47.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T15:20:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new revision tag, v3.7.0, was added to the study record history and the older v3.6.6 tag was removed, reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-09-19T18:35:27.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The study record history now lists Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a small update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-29T18:55:38.000Z thumbnail image

Stay in the know with updates to CMP-001 with Pembrolizumab: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CMP-001 with Pembrolizumab: Clinical Trial page.